Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106478325B details iridium catalyzed synthesis offering green chemistry benefits and supply chain reliability for high purity pharmaceutical intermediates manufacturing processes globally
Novel room-temperature copper catalysis for polychlorinated alkynes. Reduces energy costs and simplifies purification for high-purity pharmaceutical intermediates.
Patent CN105016938B reveals efficient N-alkyl amide synthesis. Low catalyst loading and commercial raw materials ensure cost reduction and supply reliability for pharmaceutical intermediates.
Novel asymmetric synthesis patent CN119930414B offers high yield and purity. Reliable supplier for pharma intermediates with scalable processes.
Novel patent CN116478026B offers high-yield tropone skeleton synthesis. Reduces costs and simplifies supply chain for pharmaceutical intermediates manufacturing.
Patent CN102249969A discloses a high-regioselective iridium-catalyzed method for phenyl-(3-aryl-2-propenyl) selenides, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN110551035A details high-efficiency iridium catalysis for chiral amines. Offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN105884728B details air-oxidized NHC catalysis for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN103012292A reveals a novel 2-step synthesis for dibenzo[b,f][1,2]diazocine, offering >50% yield and eliminating toxic mercury residues for reliable pharmaceutical intermediate supply.
Novel patent CN115504866B offers high-yield 4-methoxy-2-naphthol synthesis. Improves supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel two-step synthesis from styrene reduces cost and improves purity for pharmaceutical manufacturing supply chains.
Patent CN115894349A reveals a novel borylation-fluorination route for 2,3-difluoro-5-chloropyridine, offering high purity and cost reduction in agrochemical manufacturing.
Patent CN108164555B reveals a high-efficiency rare earth catalyst for boronic ester synthesis, offering mild conditions and significant cost reduction in fine chemical manufacturing.
Patent CN116332794A reveals a safe Pd-catalyzed cyanation using K4[Fe(CN)6], offering high purity aryl nitriles for pharma intermediates with reduced toxicity.
Patent CN108383863A reveals efficient lithium catalyst for borate esters. Reduces cost and time for pharmaceutical intermediate manufacturing with high purity.
Patent CN113444076A reveals a recyclable chitosan-copper catalyst for synthesizing fluorinated quinoxalinones, offering sustainable cost reduction and high purity for pharma manufacturing.
Patent CN113789527A reveals a metal-free electrochemical route for aromatic amines. Discover cost-effective, green manufacturing for high-purity pharmaceutical intermediates.
Patent CN110172710B details a green electrochemical method for pyridine carboxylates, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.